An noticeable caveat connected to the use of the Competitors binding assays in this screening is the fact that not all ligands targeting an allosteric site in a particular target automatically will compete with or modulate orthosteric radioligand binding to it. Nonetheless, most targets assayed by radioligand binding from the screening were spouse